Journals / Türk Nöroşirürji Dergsi / 2018 / Cilt: 28 - Sayı: 1

Cerebral Vasospasm: Clinical Monitoring and Treatment

Serebral Vazospazm: Klinik İzlem ve Tedavi

Pages
119–123
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we aimed to summarize the clinical course and current treatment options of cerebral vasospasm

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The main cause of focal cerebral ischemia following subarachnoid hemorrhage (SAH) is cerebral vasospasm.
📊
Key Findings & Data:The most dangerous complication following SAH is used to be considered as re-bleeding but its incidence and importance have decreased with the common use of early surgery.
💡
Conclusion & Impact:In this review, we aimed to summarize the clinical course and current treatment options of cerebral vasospasm
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The main cause of focal cerebral ischemia following subarachnoid hemorrhage (SAH) is cerebral vasospasm. Unlike other ischemic strokes, cerebral vasospasm can be clinically predicted, prevented and treated. The most dangerous complication following SAH is used to be considered as re-bleeding but its incidence and importance have decreased with the common use of early surgery. On the other hand, cerebral vasospasm has become the most dangerous complication of SAH by means of its mortality and morbidity. Therefore, the early recognition of cerebral vasospasm has utmost importance. Using preventive methods, close monitoring of the patients during the period of increased vasospasm risk after aneurysmal SAH, and starting aggressive treatment upon the slightest suspicion are the key to reducing vasospasm-related morbidity and mortality. In this review, we aimed to summarize the clinical course and current treatment options of cerebral vasospasm

Özet

Subaraknoid kanama (SAK) sonrası gelişen fokal serebral iskeminin başlıca nedeni serebral vazospazmdır. Klinik olarak diğer iskemik inmelerden farkı, ortaya çıkmasının öngörülebilirliği, önlenebilirliği ve tedavi edilebilirliğidir. Anevrizma kanamasından sonra gelişen en korkutucu komplikasyon tekrar kanama iken, erken cerrahinin yaygın olarak uygulanır olması sayesinde bu sorunun önemi giderek azalmış ve vazospazm SAK'nın mortalite ve morbidite açısından en riskli komplikasyonu haline gelmiştir. Bu nedenle, vazospazmın erken tanınması hayati önem taşımaktadır. Anevrizmal SAK geçirmiş hastalarda vazospazm gelişmesini önleyecek tedbirleri almak, özellikle vazospazm açısından en riskli günlerde hastayı çok yakından izlemek ve en ufak bir kuşkuda enerjik bir tedavi ile müdahale etmek, vazospazma bağlı mortalite ve morbiditeyi azaltmanın birinci şartıdır. Bu derlemede, serebral vazospazmın klinik seyri ve güncel tedavisi özetlenmiştir

🔖

Cite This Article

GÖKER, B., HAMAMCIOĞLU, M. K., AKÇAKAYA, M. O., KIRIŞ, T. (2022). Cerebral Vasospasm: Clinical Monitoring and Treatment. Türk Nöroşirürji Dergsi, Cilt: 28 - Sayı: 1, 119–123. https://ajindex.com/articles/637376

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Akinci IO, Sencer A, Basel A, Aras Y, Aydoseli A, Kamar C, Güresti E, Sencer S, Aydın K, Izgi N, Kiris T: Effect of lumbar puncture in patients with aneurysmal subarachnoid hemorrhage treated microsurgically or endovascularly. Acta Neurochir Suppl 115: 95-98, 2013 2. Barker FG II, Ogilvy CS: Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis. J Neurosurg 84: 405-414, 1996 3. Bejjani GK, Bank WO, Olan WJ, Sekhar LN: The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42: 979-986, 1998 4. Cross DT 3rd, Moran CJ, Angtuaco EE, Milburn JM, Diringer MN, Dacey RG Jr: Intracranial pressure monitoring during intraarterial papaverine infusion for cerebral vasospasm. AJNR Am J Neuroradiol 19(7): 1319-1323, 1998 5. Dorsch NWC: A review of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Part II: Management. J Clin Neurosci 1: 78-92, 1994 6. Dorsch NWC: Incidence, effects and treatment of ischemia following aneurysm rupture. Sano K, Takakura K, Kassell NF and Sasaki T (eds), Cerebral Vasospasm, Tokyo: Univ. of Tokyo Press, 1990:495-498 7. Ecker A, Riemenschneider PA: Arteriographic demonstration of spasm of the intracranial arteries: With special reference to saccular aneurysms. J Neurosurg 64: 594-600, 1986 8. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, Mayberg MR, Winn HR: Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 42: 510-516, 1998 9. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9, 1980 10. Fujii Y, Takahashi A, Yoshimoto T: Effect of balloon angioplasty on high grade symptomatic vasospasm after subarachnoid hemorrhage. Neurosurg Rev 18: 7-13, 1995 11. Hamilton MG, Williams FC: Perioperative management of subarachnoid hemorhage. Carter LP, Spetzler R (ed), Neurovascular Surgery, New York: Mc-Graw-Hill, 1995:603- 624 12. Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J: Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke 20(11): 1511-1515, 1989 13. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The international cooperative study on timing of aneurysm surgery. Part 1: Overall management results. J Neurosurg 73: 18-37, 1990 14. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Ze